BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• Two in Three (65%) Canadians Would Take a Drug Containing Cannabis if Prescribed by a Doctor and Covered by Insurance

  When It Comes to Cannabis, Trust in Doctors’ Judgement Runs High

  February 26, 2019

   · 

  6 min read
• Business

  Evogene Announces Establishment of Ag-Biologicals Subsidiary - LaVie Bio Ltd.

  Evogene’s activities relating to discovery, optimization and development of sustainable ag-biological products are being transferred to the new subsidiary

  February 26, 2019

   · 

  5 min read
• Business

  Aurora Cannabis Expands into Portugal, Enhancing European Market Leadership

  New Production Facility to Expand Supply to European Medical Cannabis Systems, Increasing Aurora’s International Footprint to 24 Countries

  February 26, 2019

   · 

  6 min read
• Deals

  Acerus to Report 2018 Financial Results and Host Investor Call

  Acerus Pharmaceuticals Corporation will announce financial results for the three and twelve month periods ending December 31, 2018 on Tuesday, March 05, 2019 before market opens.

  February 26, 2019

   · 

  1 min read
• Deals

  Aerpio Pharmaceuticals to Announce Fourth Quarter and Full Year 2018 Financial Results and Host Conference Call on Tuesday, March 5, 2019

  Aerpio Pharmaceuticals, Inc. announced that its fourth quarter and full year 2018 financial results will be released before the market opens on Tuesday, March 5, 2019.

  February 26, 2019

   · 

  2 min read
• Deals

  Ophthotech Reports Fourth Quarter and Full Year 2018 Financial and Operating Results

  Ophthotech Corporation announced financial and operating results for the fourth quarter and full year ended December 31, 2018 and provided a business update.

  February 26, 2019

   · 

  12 min read
• Business

  Seven Bridges Achieves Record Growth in 2018

  Record Year Solidifies Company’s Position as the Premier Biomedical Data Science Platform and Service Provider

  February 26, 2019

   · 

  2 min read
• Policy

  Celgene Corporation Announces Key Regulatory Updates for REVLIMID® in Lymphoma and Luspatercept in MDS and Beta-Thalassemia

  U.S. FDA grants Priority Review for REVLIMID® (lenalidomide) in combination with rituximab (R²) for previously treated follicular and marginal zone lymphoma

  February 26, 2019

   · 

  19 min read
• Business

  Delray Center for Healing First in Florida to Treat Patients Suffering From Obsessive-Compulsive Disorder (OCD) with Deep Transcranial Magnetic Stimulation (Deep TMS)

  Delray Center for Healing, a leading provider of mental health services in the United States, announced today that it is offering BrainsWay’s Deep Transcranial Magnetic Stimulation (Deep TMS) therapy for Obsessive-Compulsive Disorder (OCD) at its facility in Delray Beach, Florida.

  February 26, 2019

   · 

  3 min read
• BioForest

  Disagreement in Sepsis Diagnosis is Associated with Significant Antibiotic Overprescription

  Immunexpress, Inc., a molecular diagnostics company based in Seattle, announced the publication of a study, in the Journal of Intensive Care, demonstrating the challenge physicians face in making accurate and consistent clinical diagnoses of sepsis in intensive care patients.

  February 26, 2019

   · 

  4 min read